JOHN PIUS DALTON is Professor in Infectious Diseases in the School of Biological Sciences, Queen’s University Belfast and also holds a Professorial appointment in the Faculty of Science, University of Technology, Sydney, Australia. Before this he was a Canada Research Chair in Infectious Diseases at the Institute of Parasitology, McGill University, and Director of McGill’s Graduate Program in Biotechnology. Before joining McGill, Dalton was Director of the Institute for the Biotechnology of Infectious Diseases (IBID), University of Technology Sydney (UTS), Australia. He was awarded the New South Wales Government BioFirst Award in Biotechnology between 2003-2008.
Prof. Dalton received his BSc (Hons) in Zoology/Biochemistry (1980) and a PhD in Parasitology (1984) at University College Dublin. He spent postdoctoral training periods in the Johns Hopkins School of Medicine, (Baltimore, USA) and at the Laboratories of Parasitic Diseases, National Institute of Allergies and Infectious Diseases (NIAID) at the National Institutes of Health (Bethesda, MD, USA). Between 1992 and 1998 he spent several research sabbaticals at the Queensland Institute for Medical Research (QIMR), Brisbane, Australia, where he is an adjunct Professor (in 2012 he was awarded the QIMR Bancroft Fellow-in-Residence Award).
Prof. Dalton is Specialist Editor for the International Journal of Parasitology and Journal of Infectious Diseases, and an Associate Editor for PlosNTD. He is also founder and Director of Ildana Biotech Ltd, Ireland, a diagnostic and vaccine development campus company, and Helmedix Ltd, Australia whose focus is on immunotherapeutics.
His interests include vaccine development against helminth parasites of animals and humans, discovery of novel helminth parasite-derived immunotherapeutics and anti-malaria drug design. Recently, he was awarded a Royal Society Research Merit Award and European Research Council (ERC) Advanced Grant Award for the study of animal and human vaccines.